GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE INC (EIN 203403868) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

KATHERINE LANGEFELD

Phone

8472121316

Tax Period

2023-01-01 to 2023-12-31

GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE INC, founded in 2005, is a small nonprofit in the Health Care sector that reported $952K in total revenue in fiscal year 2023. Revenue surged 50% from the prior year, signaling strong growth momentum. The organization ran a surplus of $248K, a strong 26% operating margin.

Mission

TO IMPROVE AWARENESS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AMONG HEALTH PROFESSIONALS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $238,892

Investment Income $78,920

Other Revenue $634,555

TOTAL REVENUE $952,367

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $652,913

Other Expenses $704,172

TOTAL EXPENSES $704,172

Year-over-Year Comparison

	2023	2022	Change
Revenue	$952,367	$636,574	+0.5%
Expenses	$704,172	$423,986	+0.7%
Net Income	$248,195	$212,588	+0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR OBIANUJU OZOH MBBS FMCPMSC	DIRECTOR	10.00	Director	$0	$0	$0
ALVAR G AGUSTI MD	CHAIR	10.00	Officer Director	$0	$0	$0
DAVID HALPIN MD	DIRECTOR	10.00	Director	$0	$0	$0
JINGPING ZHENG MD	DIRECTOR	10.00	Director	$0	$0	$0
MARIA MONTES DE OCA	DIRECTOR	10.00	Director	$0	$0	$0
SUNDEEP SALVI	DIRECTOR	10.00	Director	$0	$0	$0
KATHERINE LANGEFELD	PROGRAM DIRE	40.00	Officer	$0	$0	$0
BARTOLOME R CELLI MD	TREASURER	10.00	Officer	$0	$0	$0
CLAUS VOGELMEIER MD	DIRECTOR	10.00	Officer	$0	$0	$0
GERARD CRINER MD	SECRETARY	10.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$952,367	$704,172	$2,958,019	$248,195
2022	$636,574	$423,986	$2,722,260	$212,588
2021	$966,952	$324,397	$2,508,622	$642,555
2020	$738,228	$410,773	$1,866,058	$327,455
2019	$922,253	$730,252	$1,538,717	$192,001
2018	$894,901	$618,508	$1,651,798	$276,393

GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE INC